Market price of Glivec disputed

The Joint Countermeasure Committee for making Glivec available to Korean patients with chronic myeloid leukemia (CML) has recently urged that the government should forcibly enforce the public price of Glivec at the price of 17,862 won/tab., since the CML patients cannot gain access to the drug in pharmacy where it has purchased Glivec from Novartis Korea at the price of 25,000 won/tab. but supp...